Loading clinical trials...
Loading clinical trials...
Systematic screening for cervical cancer stops in France at 65 years old. The incidence of certain types of gynecological neoplasia increases with age (endometrium, vulva). Diagnosis delay of 8 months...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institut de Cancérologie de Lorraine
NCT05790720 · Aged
NCT07296887 · Gynecologic Cancer, Prostate Cancer, and more
NCT05787561 · Mesonephric Gynecologic Cancer
NCT05559879 · Gynecologic Cancer, Carcinoma, and more
NCT05958316 · Symptoms and Signs, Cancer, and more
Institut de Cancérologie de Lorraine (ICL)
Vandœuvre-lès-Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions